Astrana Health (ASTH) Stock Forecast, Price Target & Predictions
ASTH Stock Forecast
Astrana Health stock forecast is as follows: an average price target of $61.67 (represents a 83.00% upside from ASTH’s last price of $33.70) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
ASTH Price Target
The average price target for Astrana Health (ASTH) is $61.67 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $70.00 to $48.00. This represents a potential 83.00% upside from ASTH's last price of $33.70.
ASTH Analyst Ratings
According to 8 Wall Street analysts, Astrana Health's rating consensus is 'Buy'. The analyst rating breakdown for ASTH stock is 0 'Strong Buy' (0.00%), 5 'Buy' (62.50%), 3 'Hold' (37.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Astrana Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 03, 2024 | David Larsen | BTIG | $70.00 | $57.87 | 20.96% | 107.72% |
| Aug 15, 2024 | Michael Ha | Robert W. Baird | $67.00 | $46.58 | 43.84% | 98.81% |
| Jun 27, 2024 | Chris O'Cull | Stifel Nicolaus | $48.00 | $40.50 | 18.52% | 42.43% |
The latest Astrana Health stock forecast, released on Oct 03, 2024 by David Larsen from BTIG, set a price target of $70.00, which represents a 20.96% increase from the stock price at the time of the forecast ($57.87), and a 107.72% increase from ASTH last price ($33.70).
Astrana Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $70.00 | $61.67 |
| Last Closing Price | $33.70 | $33.70 | $33.70 |
| Upside/Downside | -100.00% | 107.72% | 83.00% |
In the current month, the average price target of Astrana Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Astrana Health's last price of $33.70. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 14, 2024 | Cowen & Co. | Buy | Initialise | |
| Oct 10, 2024 | KeyBanc | Sector Weight | Initialise | |
| Oct 03, 2024 | BTIG | Buy | Buy | Hold |
| Jul 11, 2024 | Guggenheim | Neutral | Neutral | Hold |
| Jul 11, 2024 | Wedbush | Outperform | Outperform | Hold |
| Jul 11, 2024 | Leerink Partners | Outperform | Outperform | Hold |
| Jul 11, 2024 | Morgan Stanley | Equal-Weight | Downgrade | |
| Jul 11, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Astrana Health's last stock rating was published by Cowen & Co. on Oct 14, 2024. The company Initialise its ASTH rating from "null" to "Buy".
Astrana Health Financial Forecast
Astrana Health Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Astrana Health's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ASTH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Astrana Health EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict ASTH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Astrana Health's previous annual EBITDA (undefined) of $NaN.
Astrana Health Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Astrana Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ASTH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Astrana Health SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Astrana Health's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ASTH last annual SG&A of $NaN (undefined).
Astrana Health EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Astrana Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ASTH previous annual EPS of $NaN (undefined).